title: The beneficial effects of anisodamine for CyA hepatotoxicity in the rat and in renal-transplant recipients.
authors.affiliation: Department of Urology, Shanghai 1st People's Hospital, P.R.China.
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: X
authors.initials: X
authors.lastname: Tang
authors.forename: T
authors.initials: T
authors.lastname: Xie
authors.forename: X
authors.initials: X
authors.lastname: Sun
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects* / Q000633:toxicity*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D016166:Free Radical Scavengers / Q000494:pharmacology / Q000627:therapeutic use*; D005978:Glutathione / Q000378:metabolism; D006000:Glycocholic Acid / Q000097:blood; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000633:toxicity*; D016030:Kidney Transplantation / Q000276:immunology*; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000032:analysis; D012991:Solanaceous Alkaloids / Q000494:pharmacology / Q000627:therapeutic use*; D013482:Superoxide Dismutase / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
chemical_list: D016166:Free Radical Scavengers; D007166:Immunosuppressive Agents; D012709:Serum Albumin; D012991:Solanaceous Alkaloids; D014280:Triglycerides; C003922:anisodamine; D016572:Cyclosporine; D003577:Cytochrome P-450 Enzyme System; D013482:Superoxide Dismutase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D006000:Glycocholic Acid; D005978:Glutathione; D001663:Bilirubin